Back to results
US 12,365,704 B2Granted
Nucleic acid-polypeptide compositions and uses thereof
AssigneeAvidity Biosciences, Inc.
InventorsVenkata Ramana Doppalapudi, Michael Caramian Cochran, David Sai-Ho Chu, Joel Daniel Arias, Rob Burke
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.
Claims13
An oligonucleotide comprising a compound of Formula (IIa) at one of the termini:
- wherein;
- each R1 is independently substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 fluoroalkyl, or substituted or unsubstituted C1-C6 heteroalkyl;
- L1 is a bond, substituted or unsubstituted C1-C5 alkylene, substituted or unsubstituted C2-C5 alkenylene, or substituted or unsubstituted C2-C5 alkynylene;
- L2 is a bond, O, S, NR3, substituted or unsubstituted C4-C7 cycloalkylene, substituted or unsubstituted C4-C7 heterocycloalkylene, substituted or unsubstituted C5-C8 arylene, or substituted or unsubstituted C4-C8 heteroarylene;
- wherein R3, when present, is selected from hydrogen, unsubstituted or substituted C1-C6 alkyl, unsubstituted or substituted C1-C6 fluoroalkyl, unsubstituted or substituted C1-C6 heteroalkyl, unsubstituted or substituted monocyclic carbocycle, and unsubstituted or substituted monocyclic heterocycle;
- L3 is a bond, substituted or unsubstituted C1-C5 alkylene, substituted or unsubstituted C2-C5 alkenylene, or substituted or unsubstituted C2-C5 alkynylene;
- J is an internucleotide linking group linking to the adjacent nucleotide of the oligonucleotide;
- and
- wherein at least two of L1, L2 and L3 are not a bond.
6 more elements
Dependencies are inferred from the claim text.